GABAB Receptors and Alcohol Use Disorders: Preclinical Studies
- 18 August 2020
- book chapter
- Published by Springer Nature
- Vol. 52, 157-194
Abstract
Preclinical research over the past several decades has demonstrated a role for the γ-aminobutyric acidB (GABAB) receptor in alcohol use disorder (AUD). This chapter offers an examination of preclinical evidence on the role of the GABAB receptor on alcohol-related behaviors with a particular focus on the GABAB receptor agonist baclofen, for which effects have been most extensively studied, and positive allosteric modulators (PAMs) of the GABAB receptor. Studies employing rodent and non-human primate models have shown that activation of the GABAB receptor can reduce (1) stimulating and rewarding effects of alcohol; (2) signs of alcohol withdrawal in rats made physically dependent on alcohol; (3) acquisition and maintenance of alcohol drinking under a two-bottle alcohol versus water choice procedure; (4) alcohol intake under oral operant self-administration procedures; (5) motivational properties of alcohol measured using extinction and progressive ratio procedures; (6) the increase in alcohol intake after a period of alcohol abstinence (the alcohol deprivation effect or ADE); and (7) the ability of alcohol cues and stress to reinstate alcohol seeking when alcohol is no longer available. Baclofen and GABAB PAMs reduce the abovementioned behaviors across different preclinical models, which provides strong evidence for a significant role of the GABAB receptor in alcohol-related behaviors and supports development of medications targeting GABAB receptors for the treatment of AUD. This chapter highlights the value of examining mechanisms of alcohol-related behaviors across multiple animal models to increase the confidence in identification of new therapeutic targets.Keywords
This publication has 105 references indexed in Scilit:
- Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinkingAlcohol, 2010
- REVIEW: Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypesAddiction Biology, 2010
- Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice.Behavioral Neuroscience, 2009
- Attenuation of the Stimulant Response to Ethanol is Associated with Enhanced Ataxia for a GABAA, but not a GABAB, Receptor AgonistAlcohol, Clinical and Experimental Research, 2008
- Neurogenetic studies of alcohol addictionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Dissociation of Alcohol‐Seeking and Consumption Under a Chained Schedule of Oral Alcohol Reinforcement in BaboonsAlcohol, Clinical and Experimental Research, 2008
- Robust and stable drinking behavior following long-term oral alcohol intake in rhesus macaquesDrug and Alcohol Dependence, 2007
- Baclofen Blocks Expression and Sensitization of Anxiety‐Like Behavior in an Animal Model of Repeated Stress and Ethanol WithdrawalAlcohol, Clinical and Experimental Research, 2007
- Theγ‐Aminobutyric Acid‐B Receptor Agonist Baclofen Attenuates Responding for Ethanol in Ethanol‐Dependent RatsAlcohol, Clinical and Experimental Research, 2006
- Characterization of the ethanol-deprivation effect in substrains of C57BL/6 miceAlcohol, 2006